scispace - formally typeset
J

Jette Sønderskov Gørløv

Publications -  5
Citations -  421

Jette Sønderskov Gørløv is an academic researcher. The author has contributed to research in topics: ThioTEPA & Rituximab. The author has an hindex of 1, co-authored 2 publications receiving 277 citations.

Papers
More filters
Journal ArticleDOI

Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial.

TL;DR: The IELSG32 trial provides a high level of evidence supporting the use of MATRix combination as the new standard chemoimmunotherapy for patients aged up to 70 years with newly diagnosed primary CNS lymphoma and as the control group for future randomised trials.

P1225: secondary primary malignancies (spm) after high-dose chemotherapy (hdt) with autologous stem cell transplant (asct) for lymphoma: a danish nationwide cohort study

TL;DR: To investigate the risk and types of SPM in lymphoma patients treated with HDT-ASCT compared to the risk of malignancies in a matched background population and to explore risk factors for SPM, a nationwide matched cohort study is conducted in Denmark.